AKT1 and Hepatic fibrosis: Hence, the overall suggestion is that EX-527 inhibits the formation of EMT through the non-Smad or TGF-β1 pathway, and that TGF-β1 controls hepatic fibrosis through the Akt pathway, as shown in Figure 9.